Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

---
identifier: "/us/fr/2014-14974"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review"
title_number: 0
title_name: "Federal Register"
section_number: "2014-14974"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review"
positive_law: false
currency: "2014-06-26"
last_updated: "2014-06-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2014-14974"
document_type: "notice"
publication_date: "2014-06-26"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "79 FR 36317"
fr_volume: 79
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

The meeting announced below concerns Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements DP-14-011, initial review.

*Summary:* This document corrects a notice that was published in the *Federal Register* on June 12, 2014 (79 FR 33755). This meeting is cancelled in its entirety.

*Contact Person for More Information:* M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, *[email protected]* .

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the  Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Gary Johnson,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.